Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (41-50 of 662) with videos related to

Pageof 67
Sort By:
Progress in Biophysics and Molecular Biology|October 5, 2022
Cancer - A devastating disease, but also an eye-opener and window into the deep mysteries of life and its originsThomas W Grunt, Peter Valent
International Archives of Allergy and Immunology|March 29, 2002
Histopathological and immunohistochemical aspects of mastocytosisHans-Peter Horny, Peter Valent
Hematology. American Society of Hematology. Education Program|November 25, 2004
Chronic myelogenous leukemia and myeloproliferative diseaseStephen O'Brien, Ayalew Tefferi, Peter Valent
International Journal of Molecular Sciences|June 30, 2016
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Lisa Pleyer, Peter Valent, Richard Greil
Wiener Klinische Wochenschrift|July 2, 2024
Resolution of extravascular hemolysis with oral iptacopan monotherapy in a patient with treatment experienced paroxysmal nocturnal hemoglobinuria (PNH)Wolfgang Füreder, Renate Thalhammer, Peter Valent
Immunology and Allergy Clinics of North America|September 27, 2023
KIT Mutations and Other Genetic Defects in Mastocytosis: Implications for Disease Pathology and Targeted TherapiesYannick Chantran, Peter Valent, Michel Arock
International Journal of Molecular Sciences|June 2, 2021
Mastocytosis, MCAS, and Related Disorders-Diagnosis, Classification, and TherapyMarek Niedoszytko, Peter Valent, Bogusław Nedoszytko
Pathophysiology of Haemostasis and Thrombosis|February 5, 2005
New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotypeJohann Wojta, Kurt Huber, Peter Valent
Current Allergy and Asthma Reports|July 11, 2006
Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatmentCem Akin, Peter Valent, Luis Escribano
Expert Review of Clinical Pharmacology|January 1, 2013
The impact of molecular targets in cancer drug development: major hurdles and future strategiesAlexandra Hebar, Peter Valent, Edgar Selzer
Pageof 67

Showing results (41-50 of 662) with videos related to

Sort By:
Pageof 67
Progress in Biophysics and Molecular Biology|October 5, 2022
Cancer - A devastating disease, but also an eye-opener and window into the deep mysteries of life and its originsThomas W Grunt, Peter Valent
International Archives of Allergy and Immunology|March 29, 2002
Histopathological and immunohistochemical aspects of mastocytosisHans-Peter Horny, Peter Valent
Hematology. American Society of Hematology. Education Program|November 25, 2004
Chronic myelogenous leukemia and myeloproliferative diseaseStephen O'Brien, Ayalew Tefferi, Peter Valent
International Journal of Molecular Sciences|June 30, 2016
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Lisa Pleyer, Peter Valent, Richard Greil
Wiener Klinische Wochenschrift|July 2, 2024
Resolution of extravascular hemolysis with oral iptacopan monotherapy in a patient with treatment experienced paroxysmal nocturnal hemoglobinuria (PNH)Wolfgang Füreder, Renate Thalhammer, Peter Valent
Immunology and Allergy Clinics of North America|September 27, 2023
KIT Mutations and Other Genetic Defects in Mastocytosis: Implications for Disease Pathology and Targeted TherapiesYannick Chantran, Peter Valent, Michel Arock
International Journal of Molecular Sciences|June 2, 2021
Mastocytosis, MCAS, and Related Disorders-Diagnosis, Classification, and TherapyMarek Niedoszytko, Peter Valent, Bogusław Nedoszytko
Pathophysiology of Haemostasis and Thrombosis|February 5, 2005
New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotypeJohann Wojta, Kurt Huber, Peter Valent
Current Allergy and Asthma Reports|July 11, 2006
Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatmentCem Akin, Peter Valent, Luis Escribano
Expert Review of Clinical Pharmacology|January 1, 2013
The impact of molecular targets in cancer drug development: major hurdles and future strategiesAlexandra Hebar, Peter Valent, Edgar Selzer
Pageof 67